Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exosome-based Omic Signatures of Disease Activity in Cardiac Sarcoidosis (EXODACS)

NCT07604220 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT07604220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07604220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exosome-based Omic Signatures of Disease Activity in Cardiac Sarcoidosis (EXODACS)
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Recruiting
Start date
July 13, 2026
Completion date
July 31, 2028
Enrollment
115 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac sarcoidosis, sarcoidosis of the heart, sarcoidosis with myocarditis, sarcoidosis, cardiac